解肝煎이 Thioacetamide로 유발된 간섬유화에 미치는 영향
Effect of Haegan-jeon on Thioacetamide-Induced Liver Fibrosis
6
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: To investigate the protective effects of Haeganjeon on a thioacetamide (TAA)-induced liver fibrosis mouse model and to determine the Haegan-jeon signaling pathway. Methods: Mice were randomly divided into 4 groups: Normal group (Nor), TAA-induced liver fibrosis group (Con), TAA-induced liver fibrosis group administered 50 mg/kg silymarin (S50), TAA-induced liver fibrosis group administered 200 mg/kg Haegan-jeon (H200). The liver fibrosis mouse model was established by intraperitoneal injection with TAA three times a week for 8 weeks. During the 8 weeks, mice were orally administered silymarin and Haegan-jeon every day. At the end of the study, serum was collected to measure the levels of AST, ALT, ammonia, and myeloperoxidase (MPO). Liver tissue was harvested and analyzed by western blotting and Masson's trichrome staining. Results: Administration of Haegan-jeon suppressed the increase in serum levels of AST, ALT, ammonia, and MPO due to TAA-induced liver fibrosis. Compared to the Con group, the H200 group showed increases in antioxidant-related factors (Nrf2, HO-1, catalase, and GPx-1/2) and decreases in inflammatory-related factors (NF-κB p65, p-IκB-α, Cox-2, iNOS, TNF-α, and IL-1β) in western blots. The H200 treatment inhibited the expression of α-SMA and Collagen I. Conclusions: Haegan-jeon showed a hepatoprotective effect induced by activation of antioxidant-related factors, such as Nrf2, and it regulated the inflammation response by suppression of NF-κB.
Abstract
Objective: To investigate the protective effects of Haeganjeon on a thioacetamide (TAA)-induced liver fibrosis mouse model and to determine the Haegan-jeon signaling pathway. Methods: Mice were randomly divided into 4 groups: Normal group (Nor), TAA-induced liver fibrosis group (Con), TAA-induced liver fibrosis group administered 50 mg/kg silymarin (S50), TAA-induced liver fibrosis group administered 200 mg/kg Haegan-jeon (H200). The liver fibrosis mouse model was established by intraperitoneal injection with TAA three times a week for 8 weeks. During the 8 weeks, mice were orally administered silymarin and Haegan-jeon every day. At the end of the study, serum was collected to measure the levels of AST, ALT, ammonia, and myeloperoxidase (MPO). Liver tissue was harvested and analyzed by western blotting and Masson's trichrome staining. Results: Administration of Haegan-jeon suppressed the increase in serum levels of AST, ALT, ammonia, and MPO due to TAA-induced liver fibrosis. Compared to the Con group, the H200 group showed increases in antioxidant-related factors (Nrf2, HO-1, catalase, and GPx-1/2) and decreases in inflammatory-related factors (NF-κB p65, p-IκB-α, Cox-2, iNOS, TNF-α, and IL-1β) in western blots. The H200 treatment inhibited the expression of α-SMA and Collagen I. Conclusions: Haegan-jeon showed a hepatoprotective effect induced by activation of antioxidant-related factors, such as Nrf2, and it regulated the inflammation response by suppression of NF-κB.
참고문헌 (26)
- 김현영, "홍차 추출물 급여가 흰쥐의 간기능 개선 및 항섬유화에 미치는 영향", 동아시아식생활학회지, 23(1), pp.44~52 (2013), 동아시아식생활학회
- 이현순, "가자(Terminalia chebula Retz.) 추출물의 간섬유화 억제활성", 한국식품과학회지, 41(5), pp.597~601 (2009), 한국식품과학회
- Wang R, "Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K", AKT, Bax and caspase-3, pp.cleaved caspase-3signaling pathways, Drug Des Devel Ther[DOI]
- 김선영, "엉겅퀴 추출물의 기능 성분 분석 및 TGF-beta에 의한 간 성상 세포 활성 억제 효과", 생약학회지, 44(2), pp.110~117 (2013), 한국생약학회
- El-Gendy ZA, "Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats", Heliyon, 7(6), pp.e07159~ (2021)
- Liu Y, "Animal models of chronic liver disease", Am J Physiol Gastrointest Liver Physiol, 304(5), pp.G449~G468 (2013)
- Pérez Tamayo R, "Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis?", Hepatology, 3(1), pp.112~120 (1983)
- 이진아, "Thioacetamide 유발 급성 간 손상에 대한 모과의 효과", 한국식품영양과학회지, 50(4), pp.322~329 (2021), 한국식품영양과학회
- El-Baz FK, "Haematococcus pluvialis Carotenoids Enrich Fractions Ameliorate Liver Fibrosis Induced by Thioacetamide in Rats : Modulation of Metalloproteinase and Its Inhibitor", Biomed Res Int, 2021, pp.6631415~ (2021)
- 황태원, "解肝煎이 생쥐의 Immobilization-Stress 및 Cold-Stress에 미치는 影響", 대한한방부인과학회지, 18(3), pp.51~66 (2005), 대한한방부인과학회
- 김재광, "Nuclear factor erythroid 2-related factor 2 활성화를 통한 解肝煎의 간세포 보호 효능 및 분자기전을 활용한 解肝煎 구성 약물의 최적화 연구", 대한한의학 방제학회지, 26(3), pp.207~221 (2018), 대한한의학방제학회[DOI]
- Singleton VL, "Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents", Am J Enol Vitic, 16, pp.144~158 (1965)
- Jiao H, "Correlation of antioxidant capacities to oxygen radical scavenging enzyme activities in blackberry", J Agric Food Chem, 48(11), pp.5672~5676 (2000)
- Blois MS, "Antioxidant determinations by the use of a stable free radical", Nature, 181, pp.1199~1200 (1958)
- Re R, "Antioxidant activity applying an improved ABTS radical cation decolorization assay", Free Radical Biol Med, 26(9-10), pp.1231~1237 (1999)
- 최정원, "Hepatoprotective Effect of Uncaria rhynchophylla on Thioacetamide-Induced Liver Fibrosis Model", 대한의생명과학회지, 27(3), pp.142~153 (2021), 대한의생명과학회
- Abenavoli L, "Milk thistle(Silybum marianum) : A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases", Phytother Res, 32(11), pp.2202~2213 (2018)
- Gillessen A, "Silymarin as Supportive Treatment in Liver Diseases : A Narrative Review", Adv Ther, 37(4), pp.1279~1301 (2020)
- Ahn BT, "Antioxidative and Protective Effects of Haeganjeon Extract on Oxidative Damage of Hepatocytes", Herbal formula science, 10(2), pp.127~141 (2002)
- Pientaweeratch S, "Antioxidant, anti-collagenase and anti-elastase activities of Phyllanthus emblica, Manilkara zapota and silymarin : an in vitro comparative study for anti-aging applications", Pharm Biol, 54(9), pp.1865~1872 (2016)
- 김현정, "Immunological measurement of aspartate", alanine aminotransferase in predicting liver fibrosis and inflammation, 2020, pp.35(2), 320~330[DOI]
- De Chiara F, "Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease", Hepatology, 71(3), pp.874~892 (2020)
- Li JP, "Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol-and CCl4-induced hepatic fibrosis", Acta Pharmacol Sin, 35(8), pp.1031~1044 (2014)
- de Souza Basso B, "Methoxyeugenol deactivates hepatic stellate cells and attenuates liver fibrosis and inflammation through a PPAR-γ and NF-kB mechanism", J Ethnopharmacol, 280, pp.114433~ (2021)
- Abdel-Rahman RF, "The involvement of TGF-β1", FAK, PLoS One, pp.2021, 16(12)[DOI]
- Jia Q, "Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPARγ, LXRα and ABCA1", Int J Mol Med, 44(3), pp.893~902 (2019)